These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21707551)

  • 1. Clinical heterogeneity in Parkinson's disease revisited: a latent profile analysis.
    Flensborg Damholdt M; Shevlin M; Borghammer P; Larsen L; Ostergaard K
    Acta Neurol Scand; 2012 May; 125(5):311-8. PubMed ID: 21707551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional neuropsychological correlates and reliability of the automated neuropsychological assessment metrics-4 battery for Parkinson's disease.
    Hawkins KA; Jennings D; Vincent AS; Gilliland K; West A; Marek K
    Parkinsonism Relat Disord; 2012 Aug; 18(7):864-70. PubMed ID: 22609082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side and type of motor symptom influence cognition in Parkinson's disease.
    Katzen HL; Levin BE; Weiner W
    Mov Disord; 2006 Nov; 21(11):1947-53. PubMed ID: 16991155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between clinical characteristics of Parkinson's disease and cognitive decline.
    Locascio JJ; Corkin S; Growdon JH
    J Clin Exp Neuropsychol; 2003 Feb; 25(1):94-109. PubMed ID: 12607175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
    Martínez-Martín P; Forjaz MJ; Cubo E; Frades B; de Pedro Cuesta J;
    Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.
    Weintraub D; Moberg PJ; Culbertson WC; Duda JE; Stern MB
    Cogn Behav Neurol; 2004 Dec; 17(4):195-200. PubMed ID: 15622014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.